Regorafenib

Small molecule

Approvedregulatory verdict

Evidence outlook

Approved: Metastatic Colorectal Cancer, Hepatocellular Carcinoma, Colorectal Cancer, Advanced Metastatic Colorectal Cancer, Gastrointestinal Stromal Tumor

Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.

track record: Reliable signal

Also approved (2)
EU
  • Stivarga is indicated as monotherapy for the treatment of adult patients with: metastatic colorectal cancer (CRC) who have been previously treated with, or are not considered candidates for, available therapies - these include fluoropyrimidine-based chemotherapy, an anti-VEGF therapy and an anti-EGFR therapy; unresectable or metastatic gastrointestinal stromal tumors (GIST) who progressed on or are intolerant to prior treatment with imatinib and sunitinib; hepatocellular carcinoma (HCC) who have been previously treated with sorafenib.
Product first approved 2013EMA
JP
  • Treatment of unresectable advanced or recurrent colorectal cancer
Product first approved 2013PMDA

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase. Studies where this drug served as another program's comparator, or is merely referenced, are listed separately below.

Phase 3 (16)
Advanced Metastatic Colorectal Cancer
NCT06992648 · Second Affiliated Hospital, Zhejiang University, School of Medicine
2025-04-01 – 2027-12-31 · Colorectal Cancer Metastatic, Colorectal Cancer Recurrent
What this study did
NCT01853319 · Bayer
2013-07-24 – 2018-06-11 · Colorectal Neoplasms
What this study did
NCT01786538 · Asan Medical Center
2013-06 – 2017-05 · Metastatic Colorectal Cancer
What this study did
Colorectal Cancer
NCT07483684 · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
2026-03 – 2028-12 · HER2 IHC3+ Advanced Colorectal Cancer
What this study did
NCT07384377 · Shanghai JMT-Bio Inc.
2026-02-06 – 2028-06-15 · HER2-positive Colorectal Cancer
What this study did
NCT05794971 · Sun Yat-sen University
2023-06-10 – 2028-03-31 · Colorectal Cancer Liver Metastases, Regorafenib
What this study did
NCT06199973 · Suzhou Suncadia Biopharmaceuticals Co., Ltd.
2024-03-01 – 2026-06 · Advanced Colorectal Cancer
What this study did
Gastrointestinal Stromal Tumor
Hepatocellular Carcinoma
NCT04777851 · Translational Research in Oncology
2023-10-11 – 2026-02-26 · Carcinoma, Hepatocellular
What this study did
Other / comorbidity
NCT04879368 · Australasian Gastro-Intestinal Trials Group
2021-05-05 – 2025-04-30 · Gastro-Oesophageal Cancer
What this study did
NCT02773524 · Australasian Gastro-Intestinal Trials Group
2016-11 – 2022-12 · Gastro-Oesophageal Cancer
What this study did
NCT02664077 · NSABP Foundation Inc
2016-06 – 2019-10 · Stage III (IIIB or IIIC) Colon Cancer
What this study did
Phase 2/3 (4)
Advanced Metastatic Colorectal Cancer
NCT05462613 · Centre Hospitalier Universitaire de Besancon
2023-05-09 – 2030-11 · Metastatic Colorectal Cancer
What this study did
Colorectal Cancer
NCT01189903 · National University Hospital, Singapore
2011-01 – 2013-08 · Asian Colorectal Cancer Patients
What this study did
Other / comorbidity
NCT03970447 · Global Coalition for Adaptive Research
2019-07-30 – 2030-06 · Glioblastoma
What this study did
NCT06820957 · Children's Oncology Group
2025-11-10 – 2026-09-22 · CIC-Rearranged Sarcoma, Metastatic Ewing Sarcoma, Metastatic High Grade Sarcoma, Metastatic Undifferentiated Round Cell Sarcoma, Metastatic Undifferentiated Sarcoma, Not Otherwise Specified, Round Cell Sarcoma With EWSR1-non-ETS Fusion, Sarcoma With BCOR Genetic Alterations
What this study did
Phase 2 (142)
Advanced Metastatic Colorectal Cancer
NCT06887218 · The Methodist Hospital Research Institute
2025-05-08 – 2029-12 · Metastatic Colorectal Cancer (CRC)
What this study did
NCT03844620 · M.D. Anderson Cancer Center
2019-01-29 – 2028-08-31 · Refractory Colorectal Carcinoma, Stage III Colorectal Cancer AJCC v8, Stage IIIA Colorectal Cancer AJCC v8, Stage IIIB Colorectal Cancer AJCC v8, Stage IIIC Colorectal Cancer AJCC v8, Stage IV Colorectal Cancer AJCC v8, Stage IVA Colorectal Cancer AJCC v8, Stage IVB Colorectal Cancer AJCC v8, Stage IVC Colorectal Cancer AJCC v8
What this study did
NCT05985109 · Peking University Cancer Hospital & Institute
2023-10-26 – 2026-09-30 · Colorectal Cancer
What this study did
NCT05970705 · Fudan University
2023-07-01 – 2026-07-04 · Metastatic Colorectal Cancer
What this study did
NCT04117945 · Academic and Community Cancer Research United
2020-03-03 – 2025-03-31 · BRAF V600E Negative, KRAS Gene Mutation Negative, Locally Advanced Unresectable Colorectal Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, NRAS Gene Mutation Negative, Stage III Colorectal Cancer AJCC v8, Stage IIIA Colorectal Cancer AJCC v8, Stage IIIB Colorectal Cancer AJCC v8, Stage IIIC Colorectal Cancer AJCC v8, Stage IV Colorectal Cancer AJCC v8, Stage IVA Colorectal Cancer AJCC v8, Stage IVB Colorectal Cancer AJCC v8, Stage IVC Colorectal Cancer AJCC v8
What this study did
NCT06322563 · Tianjin Medical University Cancer Institute and Hospital
2024-04-01 – 2025-03-01 · Advanced/Metastatic Colorectal Cancer
What this study did
NCT04450836 · UNICANCER
2020-11-23 – 2024-12-31 · Metastatic Colorectal Cancer
What this study did
NCT04534218 · Centre Hospitalier Universitaire de Besancon
2020-10-16 – 2023-12-13 · Colo-rectal Cancer, Metastatic Cancer
What this study did
NCT05130021 · Maxinovel Pty., Ltd.
2022-01-31 – 2023-10-31 · Metastatic Colorectal Cancer
What this study did
NCT05730673 · CytoDyn, Inc.
2022-09-20 – 2023-08-10 · CCR5, Microsatellite Stable, Metastatic, Colorectal Cancer
What this study did
NCT04030260 · Sun Yat-sen University
2019-07-19 – 2023-07-19 · Colorectal Cancer Metastatic, MSS
What this study did
NCT02368886 · Academic and Community Cancer Research United
2015-03-27 – 2023-03-02 · Colon Adenocarcinoma, Rectal Adenocarcinoma, Stage III Colorectal Cancer AJCC v7, Stage IIIA Colorectal Cancer AJCC v7, Stage IIIB Colorectal Cancer AJCC v7, Stage IIIC Colorectal Cancer AJCC v7, Stage IV Colorectal Cancer AJCC v7, Stage IVA Colorectal Cancer AJCC v7, Stage IVB Colorectal Cancer AJCC v7
What this study did
NCT02466009 · University of Rochester
2015-03 – 2022-03-09 · Metastatic Colorectal Cancer
What this study did
NCT03880877 · Kaohsiung Medical University Chung-Ho Memorial Hospital
2019-02-26 – 2021-12-31 · Metastatic Colorectal Cancer
What this study did
NCT01298570 · UNC Lineberger Comprehensive Cancer Center
2011-04-07 – 2020-10-02 · Colorectal Cancer Metastatic
What this study did
NCT02835924 · Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
2016-07 – 2019-09 · Metastatic Colorectal Cancer
What this study did
NCT01949194 · Gerald Batist
2013-09 – 2018-12 · Metastatic Colorectal Cancer
What this study did
NCT02651415 · British Columbia Cancer Agency
2016-08 – 2018-11-07 · Metastatic Colorectal Cancer
What this study did
NCT02699073 · GERCOR - Multidisciplinary Oncology Cooperative Group
2016-02 – 2018-07-09 · Metastatic Colorectal Cancer
What this study did
NCT02402036 · Georgetown University
2015-02 – 2017-11 · Colon Cancer
What this study did
NCT02195011 · SCRI Development Innovations, LLC
2014-07 – 2017-06-04 · Colorectal Neoplasms
What this study did
NCT01875380 · Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
2013-06 – 2016-04 · Colorectal Neoplasms, Metastatic Disease
What this study did
NCT02175654 · Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
2014-06 – 2016-02 · Colorectal Neoplasms, Metastatic Disease
What this study did
NCT01289821 · Bayer
2011-02 – 2014-06 · Colorectal Neoplasms
What this study did
Colorectal Cancer
NCT07071961 · M.D. Anderson Cancer Center
2026-02-11 – 2029-05-01 · Colorectal Cancer, Regorafenib, High Risk Patients
What this study did
NCT06558773 · Chinese PLA General Hospital
2026-03-01 – 2029-03-31 · Colorectal Cancer
What this study did
NCT06829355 · Beijing Friendship Hospital
2025-02-11 – 2027-12-31 · MCRC
What this study did
NCT06930118 · Shanghai Changzheng Hospital
2025-04-10 – 2027-09-30 · Advanced Colorectal Cancer in the Third-line Treatment and Beyond, pMMR/MSS Advanced Colorectal Cancer
What this study did
NCT04701476 · Teclison Ltd.
2021-05-20 – 2027-09-30 · Colorectal Cancer; Lung Cancer
What this study did
NCT02955940 · Incyte Corporation
2016-11-30 – 2027-09-30 · Pancreatic Cancer, Colorectal Cancer (CRC), Breast Cancer, Lung Cancer
What this study did
NCT07213570 · National Cancer Institute, Naples
2025-10-16 – 2027-04 · Colorectal Cancer Metastatic
What this study did
NCT06575725 · City of Hope Medical Center
2024-11-01 – 2027-01-28 · Advanced Colon Adenocarcinoma, Advanced Colorectal Adenocarcinoma, Advanced Rectal Adenocarcinoma, Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Rectal Adenocarcinoma, Stage III Colon Cancer AJCC v8, Stage III Colorectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8, Stage IV Colon Cancer AJCC v8, Stage IV Colorectal Cancer AJCC v8, Stage IV Rectal Cancer AJCC v8
What this study did
NCT05057052 · Fudan University
2021-09-26 – 2026-09-25 · Liver Metastases, Colorectal Cancer Metastatic
What this study did
NCT04787341 · Gruppo Oncologico del Nord-Ovest
2020-12-15 – 2026-05-28 · Colorectal Cancer
What this study did
NCT06071052 · First Affiliated Hospital, Sun Yat-Sen University
2023-12-01 – 2025-12-31 · Liver Metastasis Colon Cancer
What this study did
NCT05933980 · Sun Yat-sen University
2023-12-19 – 2025-12-20 · Colorectal Cancer, Liver Metastases, MSS
What this study did
NCT06006923 · Anwaar Saeed
2024-06-26 – 2025-11-12 · MSI-H Colorectal Cancer
What this study did
NCT05894837 · Second Affiliated Hospital, Zhejiang University, School of Medicine
2023-06-01 – 2025-06-01 · Colorectal Cancer, Liver Metastases
What this study did
NCT05582031 · Translational Research in Oncology
2023-04-30 – 2025-04-30 · Anal Squamous Cell Carcinoma, Colorectal Neoplasms, Soft Tissue Sarcoma, Malignant Pleural Mesothelioma, Small Cell Lung Carcinoma, Castrate Resistant Prostate Cancer, Neuroendocrine Carcinoma of Prostate, Gastroenteropancreatic Neuroendocrine Neoplasm
What this study did
NCT05524155 · Tianjin Medical University Cancer Institute and Hospital
2022-09 – 2024-12 · Colorectal Cancer, Liver Metastasis
What this study did
NCT02619435 · National Cancer Institute, Naples
2015-11 – 2024-11 · Advanced Colorectal Cancer
What this study did
NCT05485909 · Sun Yat-sen University
2022-07-25 – 2024-06-30 · Colorectal Cancer Liver Metastases
What this study did
NCT05382741 · Ospedale Policlinico San Martino
2022-03-02 – 2024-03-02 · Colorectal Cancer Stage IV, No Evidence of Disease State
What this study did
NCT05900648 · M.D. Anderson Cancer Center
2023-05-17 – 2024-02-09 · Colorectal Cancer, Colon Cancer, Rectum Cancer
What this study did
NCT05289726 · Cancer Institute and Hospital, Chinese Academy of Medical Sciences
2022-04-18 – 2023-04-18 · Hand and Foot Skin Reaction, Colorectal Cancer Stage IV
What this study did
NCT03099486 · Fox Chase Cancer Center
2017-10-06 – 2020-06-02 · Colorectal Cancer
What this study did
NCT01929616 · Jules Bordet Institute
2013-08 – 2019-06-17 · Advanced Chemorefractory Colorectal Adenocarcinoma
What this study did
NCT03898102 · Chang Gung Memorial Hospital
2016-03 – 2019-03 · Colorectal Cancer Metastatic
What this study did
NCT02581059 · Wake Forest University Health Sciences
2016-04 – 2018-06-22 · Colorectal Cancer, Palliative Medicine, Supportive Care
What this study did
Phase 1/2 (27)
Advanced Metastatic Colorectal Cancer
NCT07750041 · CSPC Megalith Biopharmaceutical Co.,Ltd.
2026-08-30 – 2029-08-30 · Unresectable Advanced or Metastatic Colorectal Cancer
What this study did
NCT03657641 · University of Southern California
2019-06-21 – 2027-12-31 · Colorectal Cancer, Colorectal Cancer Metastatic
What this study did
NCT05672316 · City of Hope Medical Center
2023-05-11 – 2026-12-01 · Advanced Colorectal Adenocarcinoma, Advanced Microsatellite Stable Colorectal Carcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma, Stage III Colorectal Cancer AJCC v8, Stage IV Colorectal Cancer AJCC v8
What this study did
NCT07137390 · M.D. Anderson Cancer Center
2025-09-03 – 2026-01-22 · Colorectal Cancer
What this study did
NCT03828799 · Institut du Cancer de Montpellier - Val d'Aurelle
2019-05-14 – 2024-11-30 · Metastatic Colorectal Cancer
What this study did
NCT04008511 · China Medical University, China
2019-07 – 2024-03 · Metastatic Colorectal Cancer
What this study did
Colorectal Cancer
NCT06047379 · Neonc Technologies, Inc.
2023-11-01 – 2027-08-31 · Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult, Cervical Cancer, Colorectal Cancer, Esophageal Cancer, Esophageal Squamous Cell Carcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Head and Neck Squamous Cell Carcinoma, Melanoma, Merkel Cell Carcinoma, Microsatellite Instability-High Solid Malignant Tumor, Mismatch Repair Deficient Solid Malignant Tumor, Microsatellite Instability-High Colorectal Cancer, Mismatch Repair Deficient Colorectal Cancer, Non-small Cell Lung Cancer, Renal Cell Carcinoma, Small Cell Lung Cancer, Squamous Cell Carcinoma, Urothelial Carcinoma
What this study did
NCT05426811 · China Medical University, China
2022-07-01 – 2025-12-30 · Regorafenib, Raltitrexed, Colorectal Neoplasms, Third-line Treatment
What this study did
NCT03377361 · Bristol-Myers Squibb
2018-01-31 – 2024-11-04 · Colorectal Cancer, Colorectal Tumors, Colorectal Carcinoma, Colorectal Neoplasm
What this study did
NCT03946917 · Sun Yat-sen University
2019-03-12 – 2021-11-20 · Colorectal Cancer
What this study did
NCT04110093 · Shanghai Changzheng Hospital
2019-03-01 – 2021-08-31 · Colorectal Cancer, Immunotherapy
What this study did
Hepatocellular Carcinoma
NCT05773105 · Sun Yat-sen University
2023-09-19 – 2026-03-30 · Advanced Hepatocellular Carcinoma
What this study did
NCT03475953 · Institut Bergonié
2018-05-04 – 2025-12-31 · Colorectal Cancer Not MSI-H or MMR-deficient, GIST, Oesophageal or Gastric Carcinoma, Biliary Tract Cancer, Hepatocellular Carcinoma, Soft-tissue Sarcoma, Thyroid Cancer, Gastro-enteropancreatic Neuroendocrine Tumor, Non-small Cell Lung Cancer, Solid Tumor, Adult, Urothelial Carcinoma, HPV-Related Carcinoma, Triple Negative Breast Cancer, Renal Carcinoma, Mesotheliomas Pleural
What this study did
NCT05770882 · Great Novel Therapeutics Biotech & Medicals Corporation
2023-04-25 – 2025-01-17 · Hepatocellular Carcinoma (HCC)
What this study did
NCT04170556 · Fundacion Clinic per a la Recerca Biomédica
2020-03-16 – 2024-07-09 · Hepatocellular Carcinoma
What this study did
Other / comorbidity
NCT04625907 · University of Birmingham
2020-09-17 – 2030-06 · Rhabdomyosarcoma
What this study did
NCT06682611 · Shanghai Runshi Pharmaceutical Technology Co., Ltd
2024-11-13 – 2027-11-13 · Unresectable Locally Advanced or Metastatic Solid Tumors
What this study did
NCT07040228 · Junjie Hang
2025-05-26 – 2027-05-30 · Pancreatic Cancer Metastatic
What this study did
NCT04781192 · University of Kansas Medical Center
2022-03-22 – 2026-12 · Advanced Biliary Tract Cancer
What this study did
NCT05395741 · Institute of Mother and Child, Warsaw, Poland
2022-04-28 – 2026-06-30 · Osteosarcoma, Ewing Sarcoma of Bone
What this study did
NCT05394740 · National Cancer Center Hospital East
2022-06-06 – 2025-08-25 · Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma
What this study did
NCT03994601 · Bristol-Myers Squibb
2019-09-06 – 2024-08-31 · Advanced Cancer
What this study did
NCT03722108 · UNICANCER
2019-02-07 – 2022-05-19 · Adenocarcinoma of the Stomach, Adenocarcinoma of the Gastroesophageal Junction
What this study did
NCT04200404 · CStone Pharmaceuticals
2019-12-13 – 2021-08-18 · Advanced Refractory Solid Tumors
What this study did
NCT02386397 · Institut du Cancer de Montpellier - Val d'Aurelle
2014-09 – 2019-12 · Digestive Cancer
What this study did
NCT02024607 · Sumitomo Pharma America, Inc.
2014-01 – 2019-11 · Advanced Gastrointestinal Cancer
What this study did
NCT02406170 · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
2015-04 – 2019-10 · Esophageal Neoplasms, Stomach Neoplasms, Neoplasm Metastasis
What this study did
Phase 1 (45)
Advanced Metastatic Colorectal Cancer
NCT04362839 · City of Hope Medical Center
2020-05-27 – 2025-12-11 · Advanced Colon Adenocarcinoma, Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Adenocarcinoma, Stage III Colon Cancer AJCC v8, Stage III Rectal Cancer AJCC v8, Stage IIIA Colon Cancer AJCC v8, Stage IIIA Rectal Cancer AJCC v8, Stage IIIB Colon Cancer AJCC v8, Stage IIIB Rectal Cancer AJCC v8, Stage IIIC Colon Cancer AJCC v8, Stage IIIC Rectal Cancer AJCC v8, Stage IV Colon Cancer AJCC v8, Stage IV Colorectal Cancer AJCC v8, Stage IV Rectal Cancer AJCC v8, Stage IVA Colon Cancer AJCC v8, Stage IVA Colorectal Cancer AJCC v8, Stage IVA Rectal Cancer AJCC v8, Stage IVB Colon Cancer AJCC v8, Stage IVB Colorectal Cancer AJCC v8, Stage IVB Rectal Cancer AJCC v8, Stage IVC Colon Cancer AJCC v8, Stage IVC Colorectal Cancer AJCC v8, Stage IVC Rectal Cancer AJCC v8
What this study did
NCT03712943 · H. Lee Moffitt Cancer Center and Research Institute
2018-10-23 – 2024-01-18 · Colorectal Cancer, Metastatic Colorectal Cancer, Colon Cancer
What this study did
NCT03215264 · Abramson Cancer Center at Penn Medicine
2017-10-02 – 2020-06-01 · Colorectal Cancer
What this study did
NCT03081494 · Novartis Pharmaceuticals
2017-06-09 – 2019-05-07 · Metastatic Colorectal Cancer
What this study did
NCT03305913 · AIO-Studien-gGmbH
2017-07-31 – 2019-04-26 · Pretreated Metastatic Colorectal Cancer
What this study did
Colorectal Cancer
NCT06283134 · China Medical University, China
2026-03 – 2028-12-01 · Colorectal Cancer Metastatic
What this study did
NCT07343791 · JIANG LONGWEI
2025-11-19 – 2027-11-30 · DC-CIK Treatment, Regorafenib, Colorectal Cancer, Immune Combination Therapy, Iparomlimab and Tuvonralimab Injection
What this study did
NCT06283303 · China Medical University, China
2024-04-02 – 2025-11-30 · Colorectal Cancer Metastatic
What this study did
NCT06200363 · West China Hospital
2023-09-21 – 2024-11 · Advanced Colorectal Cancer
What this study did
NCT02199223 · University of Utah
2014-06 – 2016-05 · KRAS and NRAS Wild-type Colorectal Cancer
What this study did
NCT02116894 · Duke University
2014-08 – 2016-05 · Colorectal Cancer
What this study did
NCT00934882 · Bayer
2009-08 – 2012-04 · Colorectal Neoplasms
What this study did
Gastrointestinal Stromal Tumor
NCT02164240 · Dana-Farber Cancer Institute
2014-07 – 2021-05 · Gastrointestinal Stromal Tumor
What this study did
Hepatocellular Carcinoma
NCT05155189 · Zhejiang University
2022-02-21 – 2041-05 · Hepatocellular Carcinoma
What this study did
NCT05644379 · Tianjin Medical University Cancer Institute and Hospital
2022-11-24 – 2026-11 · Advanced Hepatocellular Carcinoma That Has Failed at Least One Prior Systemic Therapy
What this study did
NCT03347292 · Bayer
2018-06-18 – 2022-09-06 · Carcinoma, Hepatocellular
What this study did
Other / comorbidity
NCT06454409 · City of Hope Medical Center
2025-04-25 – 2030-09-06 · Myelodysplastic Syndrome/Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Recurrent Myelodysplastic Syndrome, Refractory Acute Myeloid Leukemia, Refractory Myelodysplastic Syndrome
What this study did
NCT05830084 · Gustave Roussy, Cancer Campus, Grand Paris
2023-06-16 – 2027-10 · Ewing Sarcoma
What this study did
NCT07567222 · West China Hospital
2026-06-05 – 2027-06-30 · Malignant Tumor
What this study did
NCT06095375 · Istituto Oncologico Veneto IRCCS
2022-07-04 – 2025-12-22 · Glioblastoma, IDH-wildtype, MGMT-Methylated Glioblastoma
What this study did
NCT05644392 · Tianjin Medical University Cancer Institute and Hospital
2022-11-25 – 2025-11-25 · Advanced Biliary Systemic Tumours That Has Failed at Least One Prior Systemic Therapy
What this study did
NCT02085148 · Bayer
2014-04-11 – 2024-03-13 · Pediatric Oncology
What this study did
NCT03042689 · Massachusetts General Hospital
2017-04-17 – 2023-02-27 · Acute Myeloid Leukemia
What this study did
NCT02910843 · Swiss Cancer Institute
2017-02-22 – 2021-12-31 · Rectal Cancer
What this study did
NCT03475251 · CStone Pharmaceuticals
2018-05-09 – 2021-05-31 · Advanced Cancer
What this study did
NCT03406871 · Kohei Shitara
2018-01-15 – 2020-12-15 · Advanced and Metastatic Solid Tumor
What this study did
NCT03878524 · OHSU Knight Cancer Institute
2020-04-01 – 2020-12-10 · Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Anatomic Stage IV Breast Cancer AJCC v8, Anemia, Ann Arbor Stage III Hodgkin Lymphoma, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Castration-Resistant Prostate Carcinoma, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Hematopoietic and Lymphoid System Neoplasm, Locally Advanced Pancreatic Adenocarcinoma, Metastatic Breast Carcinoma, Metastatic Malignant Solid Neoplasm, Metastatic Pancreatic Adenocarcinoma, Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Primary Myelofibrosis, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent Hematologic Malignancy, Recurrent Hodgkin Lymphoma, Recurrent Myelodysplastic Syndrome, Recurrent Myelodysplastic/Myeloproliferative Neoplasm, Recurrent Myeloproliferative Neoplasm, Recurrent Non-Hodgkin Lymphoma, Recurrent Plasma Cell Myeloma, Recurrent Small Lymphocytic Lymphoma, Refractory Acute Lymphoblastic Leukemia, Refractory Acute Myeloid Leukemia, Refractory Chronic Lymphocytic Leukemia, Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Refractory Chronic Myelomonocytic Leukemia, Refractory Hematologic Malignancy, Refractory Hodgkin Lymphoma, Refractory Malignant Solid Neoplasm, Refractory Myelodysplastic Syndrome, Refractory Myelodysplastic/Myeloproliferative Neoplasm, Refractory Non-Hodgkin Lymphoma, Refractory Plasma Cell Myeloma, Refractory Primary Myelofibrosis, Refractory Small Lymphocytic Lymphoma, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8, Unresectable Pancreatic Adenocarcinoma
What this study did
NCT02095054 · M.D. Anderson Cancer Center
2014-03-19 – 2020-03-27 · Advanced Cancers
What this study did
NCT02466802 · Virginia Commonwealth University
2015-07-01 – 2019-01-28 · Solid Tumor
What this study did
NCT01287598 · Bayer
2011-08-02 – 2018-07-30 · Neoplasms
What this study did
NCT02106845 · Bayer
2014-04-22 – 2018-06-12 · Neoplasms
What this study did
NCT01973868 · Bayer
2013-11-21 – 2018-04-03 · Neoplasms
What this study did
NCT02439723 · AHS Cancer Control Alberta
2016-03 – 2017-12 · Metastatic Solid Malignancies, Locally Advanced Solid Malignancies
What this study did
NCT02398513 · Bayer
2015-04 – 2016-06 · Oncology
What this study did
NCT02168777 · Bayer
2014-06-23 – 2016-04-05 · Neoplasms
What this study did
NCT01853046 · Bayer
2013-06 – 2015-11 · Neoplasms
What this study did
NCT02001909 · Bayer
2013-12 – 2014-04 · Neoplasms
What this study did
NCT00960258 · Bayer
2009-07-01 – 2013-11-11 · Tumors
What this study did
NCT01117623 · Bayer
2007-02 – 2013-11 · Neoplasm
What this study did
NCT01339104 · Bayer
2011-04 – 2013-08 · Neoplasms
What this study did
NCT01096030 · Bayer
2010-07 – 2012-11 · Neoplasms
What this study did
NCT01318265 · Bayer
2011-03 – 2011-07 · Pharmacokinetics
What this study did
NCT01322438 · Bayer
2011-03 – 2011-06 · Neoplasms
What this study did
NCT01002378 · Bayer
2009-10 – 2010-02 · Dietary Fats, Pharmacokinetics
What this study did
Phase 4 (4)
Advanced Metastatic Colorectal Cancer
NCT04874207 · Rennes University Hospital
2021-10-22 – 2025-04-11 · Colorectal Cancer Metastatic
What this study did
NCT03564938 · Bayer
2018-07-30 – 2023-12-01 · Metastatic Colorectal Cancer
What this study did
NCT02287025 · Bayer
2014-11-11 – 2016-04-08 · Physician Education
What this study did
Gastrointestinal Stromal Tumor
NCT02800330 · Erasmus Medical Center
2016-05 – 2018-02 · Colorectal Neoplasms, Gastrointestinal Stromal Tumors
What this study did
Early phase / not applicable (10)
Advanced Metastatic Colorectal Cancer
NCT05818267 · Wei Zhang
2023-06-26 – 2025-11 · Colorectal Cancer
What this study did
NCT03698253 · Kaohsiung Medical University Chung-Ho Memorial Hospital
2013-10-01 – 2018-06-01 · Colorectal Cancer
What this study did
NCT01996969 · Seoul National University Hospital
2013-10 – 2016-05 · Metastatic Colorectal Cancer
What this study did
Colorectal Cancer
NCT06456515 · The First People's Hospital of Changzhou
2024-05-01 – 2026-03 · Colorectal Cancer Metastatic
What this study did
NCT02175095 · Asan Medical Center
2014-07-18 – 2019-04-30 · Colorectal Cancer
What this study did
Hepatocellular Carcinoma
NCT07115550 · Huai'an First People's Hospital
2025-08-26 – 2028-08-26 · Hepatocellular Carcinoma (HCC)
What this study did
Other / comorbidity
NCT04055220 · Centre Leon Berard
2020-03-03 – 2026-10-01 · Bone Sarcoma, Osteosarcoma, Ewing Sarcoma, Chondrosarcoma, Undifferentiated Pleomorphic Sarcoma, Leiomyosarcoma, Angiosarcoma
What this study did
NCT06856590 · Gazi University
2025-02-20 – 2025-09-07 · Hand-Foot Skin Reaction (HFSR)
What this study did
NCT05759195 · Fondazione Policlinico Universitario Agostino Gemelli IRCCS
2021-01-07 – 2024-12-31 · Glioblastoma, Glioblastoma, IDH-wildtype
What this study did
NCT03956940 · Institut du Cancer de Montpellier - Val d'Aurelle
2019-10-04 – 2021-12-31 · Hepatocarcinoma
What this study did
Used as active comparator (28)

Other programs' studies in which this drug was the registered active-comparator arm: a marker of standard-of-care status, not evidence of this drug's own progression.

Phase 3 (12)
Advanced Metastatic Colorectal Cancer
NCT07134205 · Shanghai JMT-Bio Inc.
2025-10-01 – 2028-10-01 · Metastatic Colorectal Cancer (mCRC)
What this study did
NCT05425940 · Exelixis
2022-09-07 – 2027-01-31 · Colorectal Cancer
What this study did
NCT05328908 · Bristol-Myers Squibb
2022-04-28 – 2025-07-14 · Colorectal Neoplasms
What this study did
NCT02934529 · Ludwig-Maximilians - University of Munich
2015-03 – 2025-01-30 · Metastatic Colorectal Cancer
What this study did
Colorectal Cancer
NCT07730489 · Sichuan Baili Pharmaceutical Co., Ltd.
2026-08 – 2027-12 · Colorectal Cancer
What this study did
NCT05198934 · Amgen
2022-04-19 – 2026-04-14 · Colorectal Cancer (CRC)
What this study did
Hepatocellular Carcinoma
NCT04985136 · Jiangsu HengRui Medicine Co., Ltd.
2021-09-26 – 2021-12-29 · Advanced Hepatocellular Carcinoma (HCC)
What this study did
Other / comorbidity
NCT03465722 · Blueprint Medicines Corporation
2018-03-26 – 2021-09-15 · GIST
What this study did
Phase 2/3 (3)
Gastrointestinal Stromal Tumor
NCT07379047 · Ningbo Newbay Technology Development Co., Ltd
2026-05-11 – 2028-09-01 · GIST - Gastrointestinal Stromal Tumor, Advanced
What this study did
Hepatocellular Carcinoma
NCT07392866 · Nanjing Sanhome Pharmaceutical, Co., Ltd.
2026-03-01 – 2030-03-01 · Hepatocellular Carcinoma (HCC)
What this study did
NCT07300488 · Xi'an Xintong Pharmaceutical Research Co.,Ltd.
2025-09-01 – 2027-04-30 · HCC
What this study did
Phase 2 (8)
Advanced Metastatic Colorectal Cancer
NCT06949982 · Sergey Orlov, MD
2025-03-17 – 2027-10 · Metastatic Colorectal Cancer (mCRC), Colorectal Neoplasms
What this study did
NCT06543836 · Cancer Institute and Hospital, Chinese Academy of Medical Sciences
2023-12-01 – 2025-11-30 · Metastatic Colorectal Cancer
What this study did
NCT06089330 · Shanghai JMT-Bio Inc.
2024-01 – 2024-12 · Metastatic Colorectal Cancer (mCRC)
What this study did
NCT02096354 · EpicentRx, Inc.
2014-05 – 2020-10-08 · Colorectal Neoplasms
What this study did
Colorectal Cancer
NCT03992456 · Academic and Community Cancer Research United
2020-04-24 – 2024-10-07 · Metastatic Colon Adenocarcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Adenocarcinoma, Stage III Colon Cancer AJCC v8, Stage III Colorectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8, Stage IIIA Colon Cancer AJCC v8, Stage IIIA Colorectal Cancer AJCC v8, Stage IIIA Rectal Cancer AJCC v8, Stage IIIB Colon Cancer AJCC v8, Stage IIIB Colorectal Cancer AJCC v8, Stage IIIB Rectal Cancer AJCC v8, Stage IIIC Colon Cancer AJCC v8, Stage IIIC Colorectal Cancer AJCC v8, Stage IIIC Rectal Cancer AJCC v8, Stage IV Colon Cancer AJCC v8, Stage IV Colorectal Cancer AJCC v8, Stage IV Rectal Cancer AJCC v8, Stage IVA Colon Cancer AJCC v8, Stage IVA Colorectal Cancer AJCC v8, Stage IVA Rectal Cancer AJCC v8, Stage IVB Colon Cancer AJCC v8, Stage IVB Colorectal Cancer AJCC v8, Stage IVB Rectal Cancer AJCC v8, Stage IVC Colon Cancer AJCC v8, Stage IVC Colorectal Cancer AJCC v8, Stage IVC Rectal Cancer AJCC v8, Unresectable Colon Adenocarcinoma, Unresectable Colorectal Carcinoma, Unresectable Rectal Adenocarcinoma
What this study did
NCT02316340 · The University of Texas Health Science Center at San Antonio
2015-02-11 – 2018-04-16 · Colorectal Cancer
What this study did
Hepatocellular Carcinoma
NCT07328009 · Fudan University
2026-01-19 – 2029-01-15 · Hepato Cellular Carcinoma (HCC)
What this study did
NCT07310173 · Zhejiang Hisun Pharmaceutical Co. Ltd.
2026-01-01 – 2027-12-01 · HCC - Hepatocellular Carcinoma
What this study did
Phase 1/2 (4)
Advanced Metastatic Colorectal Cancer
NCT04660812 · Arcus Biosciences, Inc.
2021-05-10 – 2025-09-05 · Metastatic Colorectal Cancer
What this study did
NCT03555149 · Hoffmann-La Roche
2018-09-27 – 2022-09-26 · Colorectal Cancer
What this study did
NCT01896856 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2013-10-23 – 2019-08-26 · Previously Treated Metastatic Colorectal Cancer
What this study did
Other / comorbidity
NCT07857135 · CSPC Megalith Biopharmaceutical Co.,Ltd.
2026-10-03 – 2029-08-03 · Advanced/Metastatic Solid Tumors
What this study did
Early phase / not applicable (1)
Other / comorbidity
NCT07537985 · Sun Yat-sen University
2020-01-01 – 2025-12-25 · Hepatocellulcar Carcinoma
What this study did
Appears in other studies (9)

Studies that reference this drug without giving it an intervention arm of its own: other formulations' programs, background therapy, or registry-search bleed.

Phase 3 (1)
Advanced Metastatic Colorectal Cancer
NCT03829462 · Institut du Cancer de Montpellier - Val d'Aurelle
2019-03-28 – 2026-09 · Metastatic Colorectal Cancer (mCRC)
What this study did
Phase 2 (6)
Advanced Metastatic Colorectal Cancer
NCT06425133 · Centre Hospitalier Universitaire de Besancon
2024-07-19 – 2028-09 · Metastatic Colorectal Cancer
What this study did
NCT05963490 · Fudan University
2023-04-25 – 2026-04-25 · Microsatellite Stable Metastatic Colorectal Cancer
What this study did
Colorectal Cancer
NCT07003022 · Fudan University
2025-06-01 – 2028-05-01 · Colo-rectal Cancer, MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers
What this study did
NCT02119676 · Incyte Corporation
2014-03 – 2016-12 · CRC (Colorectal Cancer)
What this study did
Hepatocellular Carcinoma
NCT07100392 · Fudan University
2025-08-14 – 2028-08-01 · Hepatocellular Carcinoma (HCC)
What this study did
Other / comorbidity
Phase 1/2 (1)
Colorectal Cancer
NCT03563157 · ImmunityBio, Inc.
2018-09-28 – 2019-08-21 · Colorectal Cancer Metastatic, mCRC
What this study did
Early phase / not applicable (1)
Hepatocellular Carcinoma
NCT05233358 · The Central Hospital of Lishui City
2022-02-01 – 2025-02-01 · Hepatocellular Carcinoma
What this study did

Competitive landscape

Other Multi-kinase inhibitor (VEGFR/PDGFR/KIT) drugs

Pazopanib. Compare all 2 Multi-kinase inhibitor (VEGFR/PDGFR/KIT) drugs

1 other tracked programme targets this mechanism, none of them ahead of this one.

This drug's own stage for Advanced Metastatic Colorectal Cancer: Approved. Competitors below are sorted furthest-along first.

DrugStageModalityMechanismEvidence signalReported efficacygraded featured trials
Regorafenib: this drugApprovedSmall moleculeMulti-kinase inhibitor (VEGFR/PDGFR/KIT)Reliable signal
NCT01584830: Overall survival: hazard ratio 0·55 regorafenib vs placebo (median 8·8 months vs 6·3 months; one-sided p=0·00016)
Alymsys (bevacizumab-Maly)ApprovedMonoclonal antibodyVEGF-Anot yet gradedNo reviewed efficacy summary in this indication
Bevacizumab-Awwb (MVASI)ApprovedMonoclonal antibodyVEGF-Anot yet gradedNo reviewed efficacy summary in this indication
EncorafenibApprovedSmall moleculeBRAF V600Enot yet gradedNo reviewed efficacy summary in this indication
Fruquintinib (Fruzaqla / Elunate)ApprovedSmall moleculeVEGFR1/2/3Reliable signal
NCT04322539: Median overall survival 7.4 months with fruquintinib (95% CI 6.7 to 8.2) vs 4.8 months with placebo (95% CI 4.0 to 5.8); stratified HR 0.662 (95% CI 0.549 to 0.800), p<.001
IpilimumabApprovedMonoclonal antibodyCTLA-4 antagonistnot yet gradedNo reviewed efficacy summary in this indication
Jobevne (bevacizumab-Nwgd)ApprovedMonoclonal antibodyVEGF-Anot yet gradedNo reviewed efficacy summary in this indication
NivolumabApprovedMonoclonal antibodyPD-1Weak signalNo reviewed efficacy summary in this indication
Opdivo QvantigApprovedMonoclonal antibodyPD-1not yet gradedNo reviewed efficacy summary in this indication
Pazopanib (Votrient)
Approved(overall)
Small moleculeMulti-kinase inhibitor (VEGFR/PDGFR/KIT)
Reliable signal(overall)
No reviewed efficacy summary in this indication
RamucirumabApprovedMonoclonal antibodyVEGFR2Partial signal
NCT01183780: Overall Survival (OS) (Randomization to Date of Death from Any Cause Up to 39.36 Months): Ramucirumab + FOLFIRI 13.3 months (95% CI 12.4 to 14.5) | Placebo + FOLFIRI 11.7 months (95% CI 10.8 to 12.7)
SotorasibApprovedSmall moleculeKRAS G12Cnot yet gradedNo reviewed efficacy summary in this indication
TucatinibApprovedSmall moleculeHER2Partial signal
NCT03043313: Confirmed Objective Response Rate (cORR) Per RECIST v1.1 Per Blinded Independent Central Review (BICR) in Pooled Cohorts A+B (Up to 46.6 months): Tucatinib+Trastuzumab (Cohorts A+B) 39.3 Percentage of Participants (95% CI 28.8 to 50.5)
Vegzelma (bevacizumab-Adcd)ApprovedMonoclonal antibodyVEGF-Anot yet gradedNo reviewed efficacy summary in this indication
Zirabev (bevacizumab-Bvzr)ApprovedMonoclonal antibodyVEGF-Anot yet gradedNo reviewed efficacy summary in this indication
Telisotuzumab AdizutecanPhase 3Antibody–drug conjugateMETnot yet gradedNo reviewed efficacy summary in this indication
BafisontamabPhase 2Multispecific antibodyEGFR x c-METnot yet gradedNo reviewed efficacy summary in this indication
PelareorepPhase 2Oncolytic virusTumor cells (oncolytic replication)not yet gradedNo reviewed efficacy summary in this indication

Upcoming events

(38 total)

Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Follow Regorafenib to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.

Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2026 (5)
December 2026 (5)
Phase 2Melanoma Stage III, Melanoma Stage IVActive not recruiting
Est. primary completion 2026-12 · NCT05370807 · CT.gov ↗
What to watch
Phase 1Malignant TumorRecruiting
Est. primary completion 2026-12-31 · NCT07567222 · CT.gov ↗
What to watch
Phase 2Rectal Cancer Stage II, Rectal Cancer Stage IIIActive not recruiting
Est. primary completion 2026-12-31 · NCT04503694 · CT.gov ↗
What to watch
Phase 2Digestive System CancersActive not recruiting
Est. primary completion 2026-12-31 · NCT06099821 · CT.gov ↗
What to watch
Phase 2Gastrointestinal Stromal TumorRecruiting
Est. primary completion 2026-12-31 · NCT05366816 · CT.gov ↗
What to watch
2027 (21)
February 2027 (2)
Phase 2Esophagogastric Cancer, HER2-NegativeActive not recruiting
Est. primary completion 2027-02 · NCT04757363 · CT.gov ↗
What to watch
Phase 1/2Colorectal CancerRecruiting
Est. primary completion 2027-02-28 · NCT06047379 · CT.gov ↗
What to watch
March 2027 (3)
Phase 2Colorectal CancerRecruiting
Est. primary completion 2027-03-01 · NCT06558773 · CT.gov ↗
What to watch
Phase 2Colorectal CancerRecruiting
Est. primary completion 2027-03-31 · NCT04701476 · CT.gov ↗
What to watch
Phase 3Colorectal CancerRecruiting
Est. primary completion 2027-03-31 · NCT05794971 · CT.gov ↗
What to watch
April 2027 (2)
Phase 1Ewing SarcomaActive not recruiting
Est. primary completion 2027-04 · NCT05830084 · CT.gov ↗
What to watch
Phase 2Colorectal CancerRecruiting
Est. primary completion 2027-04-30 · NCT06930118 · CT.gov ↗
What to watch
May 2027 (2)
Phase 2Colorectal CancerRecruiting
Est. primary completion 2027-05-01 · NCT07071961 · CT.gov ↗
What to watch
Phase 1/2Pancreatic Cancer MetastaticRecruiting
Est. primary completion 2027-05-30 · NCT07040228 · CT.gov ↗
What to watch
June 2027 (1)
Phase 2Gastrointestinal Stromal TumorRecruiting
Est. primary completion 2027-06-01 · NCT07559864 · CT.gov ↗
What to watch
July 2027 (1)
Phase 2Gastrointestinal Stromal TumorNot yet recruiting
Est. primary completion 2027-07-30 · NCT06772233 · CT.gov ↗
What to watch
August 2027 (2)
Phase 3Colorectal CancerNot yet recruiting
Est. primary completion 2027-08 · NCT07483684 · CT.gov ↗
What to watch
Early phase / not applicableHepatocellular CarcinomaNot yet recruiting
Est. primary completion 2027-08-26 · NCT07115550 · CT.gov ↗
What to watch
September 2027 (2)
Phase 2Cancer, Tumors, Neoplasm, NeoplasiaRecruiting
Est. primary completion 2027-09 · NCT02925234 · CT.gov ↗
What to watch
Phase 2Colorectal CancerActive not recruiting
Est. primary completion 2027-09-30 · NCT02955940 · CT.gov ↗
What to watch
November 2027 (2)
Phase 1Colorectal CancerRecruiting
Est. primary completion 2027-11-30 · NCT07343791 · CT.gov ↗
What to watch
Phase 3Colorectal CancerNot yet recruiting
Est. primary completion 2027-11-30 · NCT07384377 · CT.gov ↗
What to watch
December 2027 (4)
Phase 1Colorectal CancerNot yet recruiting
Est. primary completion 2027-12-01 · NCT06283134 · CT.gov ↗
What to watch
Phase 2Gastric/Gastroesophageal Junction AdenocarcinomaNot yet recruiting
Est. primary completion 2027-12-30 · NCT07148427 · CT.gov ↗
What to watch
Phase 1/2Metastatic Colorectal CancerNot yet recruiting
Est. primary completion 2027-12-31 · NCT07750041 · CT.gov ↗
What to watch
Phase 3Metastatic Colorectal CancerRecruiting
Est. primary completion 2027-12-31 · NCT06992648 · CT.gov ↗
What to watch
2028 (8)
April 2028 (2)
Phase 2Hepatocellular CarcinomaNot yet recruiting
Est. primary completion 2028-04 · NCT07495579 · CT.gov ↗
What to watch
Phase 2Solid Malignant TumorsActive not recruiting
Est. primary completion 2028-04-27 · NCT06246643 · CT.gov ↗
What to watch
May 2028 (2)
Phase 2Hepatocellular CarcinomaNot yet recruiting
Est. primary completion 2028-05-31 · NCT07514455 · CT.gov ↗
What to watch
Phase 2Hepatocellular CarcinomaNot yet recruiting
Est. primary completion 2028-05-31 · NCT07514429 · CT.gov ↗
What to watch
June 2028 (1)
Phase 2/3GlioblastomaRecruiting
Est. primary completion 2028-06 · NCT03970447 · CT.gov ↗
What to watch
August 2028 (1)
Phase 2Metastatic Colorectal CancerActive not recruiting
Est. primary completion 2028-08-31 · NCT03844620 · CT.gov ↗
What to watch
December 2028 (2)
Phase 2Metastatic Colorectal CancerRecruiting
Est. primary completion 2028-12 · NCT06887218 · CT.gov ↗
What to watch
Phase 2Meningioma, MalignantRecruiting
Est. primary completion 2028-12 · NCT06275919 · CT.gov ↗
What to watch
2029 (1)
November 2029 (1)
Phase 2/3Metastatic Colorectal CancerActive not recruiting
Est. primary completion 2029-11 · NCT05462613 · CT.gov ↗
What to watch
2030 (1)
June 2030 (1)
Phase 1/2RhabdomyosarcomaRecruiting
Est. primary completion 2030-06 · NCT04625907 · CT.gov ↗
What to watch
2031 (1)
November 2031 (1)
Phase 2Advanced Cancer, Solid Tumor, Haematological MalignancyRecruiting
Est. primary completion 2031-11-25 · NCT05159245 · CT.gov ↗
What to watch
2032 (1)
July 2032 (1)
Phase 2Gastrointestinal Stromal TumorActive not recruiting
Est. primary completion 2032-07-01 · NCT06087263 · CT.gov ↗
What to watch

See the full readout calendar ↗